Hochschulschrift
Molecular determinants of therapy response in metastatic clear cell renal cell carcinoma (MORE study)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
II, 63 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2017
- Schlagwort
-
Krebs
Onkologie
Harnorgan
Niere
Harnleiter
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2017]
Ähnliche Objekte (12)
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
The role of PBRM1 in clear cell renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Capecitabine in the treatment of metastatic renal cell carcinoma
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma
Characterisation of spontaneous proximal tubule formation in vitro and development of a metastatic clear cell renal cell carcinoma (ccRCC) model
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
The role of cyclin-dependent kinase 18 (CDK18) in clear cell renal cell carcinoma
Lipocalin-2 and its specific receptor LCN-2R in clear cell renal cell carcinoma
Comparative translational, transcriptional, and functional profiling of clear cell and papillary renal cell carcinoma
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
The role of PBRM1 in clear cell renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Capecitabine in the treatment of metastatic renal cell carcinoma
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma
Characterisation of spontaneous proximal tubule formation in vitro and development of a metastatic clear cell renal cell carcinoma (ccRCC) model
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
The role of cyclin-dependent kinase 18 (CDK18) in clear cell renal cell carcinoma
Lipocalin-2 and its specific receptor LCN-2R in clear cell renal cell carcinoma
Comparative translational, transcriptional, and functional profiling of clear cell and papillary renal cell carcinoma
Deep learning can predict survival directly from histology in clear cell renal cell carcinoma
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
The role of PBRM1 in clear cell renal cell carcinoma
Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Capecitabine in the treatment of metastatic renal cell carcinoma
Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma
Characterisation of spontaneous proximal tubule formation in vitro and development of a metastatic clear cell renal cell carcinoma (ccRCC) model
VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
The role of cyclin-dependent kinase 18 (CDK18) in clear cell renal cell carcinoma
Lipocalin-2 and its specific receptor LCN-2R in clear cell renal cell carcinoma
Comparative translational, transcriptional, and functional profiling of clear cell and papillary renal cell carcinoma